Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery.
暂无分享,去创建一个
Yuki Takahashi | Makiya Nishikawa | Yoshinobu Takakura | Y. Takakura | M. Nishikawa | Kohta Mohri | Yuki Takahashi | Kohei Ogawa | Kohta Mohri | Natsuki Takahashi | Kohei Ogawa | R. Takahashi | Rei Takahashi | Yuka Umeki | Yohji Kawasaki | Hiroshi Watanabe | Eri Kusuki | Yuka Umeki | Yohji Kawasaki | Hiroshi Watanabe | Eri Kusuki | Natsuki Takahashi
[1] Dan Luo,et al. Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice. , 2011, Biomaterials.
[2] M. Huggins. Viscoelastic Properties of Polymers. , 1961 .
[3] D. Luo,et al. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity. , 2009, Biomaterials.
[4] Y. Takakura,et al. Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] Dongsheng Liu,et al. A pH-triggered, fast-responding DNA hydrogel. , 2009, Angewandte Chemie.
[6] D. Klinman. Immunotherapeutic uses of CpG oligodeoxynucleotides , 2004, Nature Reviews Immunology.
[7] P. Rothemund. Folding DNA to create nanoscale shapes and patterns , 2006, Nature.
[8] Hao Yan,et al. Challenges and opportunities for structural DNA nanotechnology. , 2011, Nature nanotechnology.
[9] Y. Takakura,et al. Injection site‐dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination , 2010, The journal of gene medicine.
[10] M. Hashida,et al. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. , 2001, The Journal of pharmacology and experimental therapeutics.
[11] Allan S Hoffman,et al. Hydrogels for biomedical applications. , 2002, Advanced drug delivery reviews.
[12] R. Larson. The Structure and Rheology of Complex Fluids , 1998 .
[13] Soong Ho Um,et al. Dendrimer-like DNA-based fluorescence nanobarcodes , 2006, Nature Protocols.
[14] 장윤희,et al. Y. , 2003, Industrial and Labor Relations Terms.
[15] Soong Ho Um,et al. Enzyme-catalysed assembly of DNA hydrogel , 2006, Nature materials.
[16] P. McEuen,et al. Controlled assembly of dendrimer-like DNA , 2004, Nature materials.
[17] Antonios G Mikos,et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[18] Y. Takakura,et al. Enhanced immunostimulatory activity of oligodeoxynucleotides by Y‐shape formation , 2008, Immunology.
[19] N. Seeman,et al. Synthesis from DNA of a molecule with the connectivity of a cube , 1991, Nature.
[20] D. Luo,et al. A mechanical metamaterial made from a DNA hydrogel. , 2012, Nature nanotechnology.
[21] R. Purcell,et al. Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.
[22] Hao Yan,et al. A DNA nanostructure platform for directed assembly of synthetic vaccines. , 2012, Nano letters.
[23] Tomoki Shiomi,et al. Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells. , 2012, ACS nano.
[24] J. Karbach,et al. Therapeutic administration of a synthetic CpG oligodeoxynucleotide triggers formation of anti-CpG antibodies. , 2012, Cancer research.
[25] Y. Takakura,et al. DNA-based nano-sized systems for pharmaceutical and biomedical applications. , 2010, Advanced drug delivery reviews.
[26] A. Krieg,et al. Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.
[27] Tao Zhang,et al. Self‐Assembled DNA Hydrogels with Designable Thermal and Enzymatic Responsiveness , 2011, Advanced materials.
[28] D. Klinman,et al. Use of CpG oligodeoxynucleotides as immune adjuvants , 2004, Immunological reviews.
[29] Nadrian C. Seeman,et al. An Overview of Structural DNA Nanotechnology , 2007, Molecular biotechnology.
[30] D. Richman,et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.
[31] H. Kiyono,et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. , 2010, Nature materials.
[32] C. Mao,et al. Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra , 2008, Nature.
[33] G. Hartmann,et al. Accessing the therapeutic potential of immunostimulatory nucleic acids. , 2008, Current opinion in immunology.
[34] S. Vogel,et al. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming , 2007, Proceedings of the National Academy of Sciences.
[35] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[36] J. P. Shea,et al. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. , 1994, The Journal of pharmacology and experimental therapeutics.
[37] Andrew E. Parker,et al. Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.
[38] Jae-Geun Yoon,et al. Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases. , 2003, International immunology.